Health minister stands by coronavirus vaccine plan despite concerns about AstraZeneca efficacy

Modesto Morganelli
Gennaio 13, 2021

There are no questions about the safety of the AstraZeneca option or the need for a vaccine.

If endorsed by the EMA and formally approved by the European Commission, the AstraZeneca vaccine would become the third coronavirus inoculation available in the bloc after BioNTech-Pfizer's shot and Moderna's jab.

"I think the [vaccine rollout] plan is robust but it is being able to ... pivot towards getting more of [those] vaccines, I think that makes a lot of sense".

"We're not the only country in the world that has AstraZeneca ordered".

The AstraZeneca vaccine has the major advantages of being both easier to store than others and relatively low-priced, costing about 2.75 euros ($3.40) per dose.

The Australia and New Zealand Society for Immunology says, based on current evidence, the AstraZeneca vaccine shouldn't be relied on for controlling the virus in Australia.

Phase three trial results from the AstraZeneca vaccine published in the Lancet showed the vaccine was 62.1 per cent effective at preventing disease when given in standard doses.

Vaccines from Moderna and Pfizer have achieved higher than 90 per cent efficacy, according to medical trials.

A spokesperson for Health Minister Greg Hunt said the Government's decisions were "being driven by the combination of scientific advice from medical experts" on the advisory body chaired by former Chief Medical Officer Professor Brendan Murphy.

"It would be better if the Federal Government had more deals, more advanced supply agreements in place", he told the ABC.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE